Feedback sought on draft National Code of Practice for Chemicals of Security Concern
21 January, 2013Australian governments have decided to pursue a voluntary code of practice for businesses that manage, handle or use products containing 11 chemicals identified as having the potential to be used to make homemade explosives.
New clinical genomics company launches
17 January, 2013Boston Children’s Hospital has partnered with Life Technologies Corporation to launch Claritas Genomics, a company formed to develop next-generation genetic and genomics-based diagnostic testing solutions.
LifeSensors appoints new distributor
16 January, 2013 | Supplied by: http://www.lifesensors.com/LifeSensors has appointed United Bioresearch Products as its new Australian distributor.
2013 Academy awards for scientific excellence announced
16 January, 2013The Australian Academy of Science today announced the 2013 winners of its prestigious annual awards for scientific excellence.
Bio-Rad acquires AbD Serotec
15 January, 2013Bio-Rad Laboratories, a multinational manufacturer and distributor of life science research and clinical diagnostic products, has announced that it has purchased AbD Serotec, a division of MorphoSys AG, for approximately €53 million in cash.
Academic and biotechnology industry alliance wins $300,000 grant
15 January, 2013The Victorian Government has provided $300,000 to the Victorian Infection and Immunity Network (VIIN) as part of its Collaborative Networks Pilot Program to encourage the development of partnerships between academic and industry groups and to accelerate industry’s adoption of new technologies.
New appointments at the Australian Synchrotron
14 January, 2013The Australian Nuclear Science and Technology Organisation (ANSTO) has announced a series of new appointments at the Australian Synchrotron.
UNSW secures Australia-China joint research centre
19 December, 2012The University of New South Wales (UNSW) has secured funding for one of six new Australia-China joint research centres, which aims to meet the challenges facing the minerals, metallurgy and materials industries in both countries.
A new era of science partnership between Australia and China
14 December, 2012The Australian Nuclear Science and Technology Organisation (ANSTO) has welcomed the signing of a research agreement celebrating the 40th anniversary of diplomatic relationships between Australia and China.
Industry sponsorship leads to bias in reported findings of clinical trials
14 December, 2012Studies reporting the results of industry-sponsored clinical trials present a more favourable picture of the effects of drugs and medical devices than those reporting on non-industry-sponsored trials, according to a Cochrane systematic review.
2013 BIO International Convention: call for expressions of interest
12 December, 2012The 2013 Australian Delegation to biotechnology convention BIO, being managed by AusBiotech, gives Australian companies and research organisations a chance to participate on the Australian pavilion at the event.
Renewed agreement opens paths to better science for Australia and India
05 December, 2012Scientists in Australia and India can look forward to greater levels of cooperation and collaboration after the Australian Academy of Science and Indian National Academy of Science today renewed their commitment to work more closely together.
Big Pharma doing more for access to medicine in developing countries than two years ago
30 November, 2012The latest Access to Medicine Index, which ranks the top 20 pharmaceutical companies on their efforts to improve access to medicine in developing countries, finds that the industry is doing more than it was two years ago.
Scientist’s sons sue CIA over covert mind control testing and murder
30 November, 2012In the 1950s and 60s, the CIA was covertly administering LSD to US citizens as it attempted to develop mind control technologies. One family is now alleging murder.
New policy brings clarity and consistency to drug names
29 November, 2012To provide greater clarity and consistency in naming practices for medicines, a new drug naming policy established by the United States Pharmacopeial Convention (USP) will become official on 1 May 2013.
